Table 1.
Sociodemographics of the study sample (n = 500).
Table 2.
Perceptions of the efficacy and safety of glucocorticoids among the study participants.
Fig 1.
The prevalence of the real-time adverse effects encountered by the GC users (n = 315).
Table 3.
Correlation between Socio-demographics and perceived efficacy and safety of GCs.